StockWatch
·
Biotechnology: Pharmaceutical Preparations
Quarterly ResultMay 15, 2026, 04:39 PM

Inflection Point Q1 Net Income $240K; Going Concern Warning

AI Summary

Inflection Point Acquisition Corp. V reported a net income of $240,456 for the first quarter of 2026, a decrease compared to $379,937 in the same period last year, primarily due to a significant increase in formation and operating costs. The company also disclosed a working capital deficit of $2,424,808 and raised substantial doubt about its ability to continue as a going concern, contingent on completing its business combination with GOWell Technology Limited by August 14, 2026.

Key Highlights

  • Net income for Q1 2026 was $240,456, a decrease from $379,937 in Q1 2025.
  • Formation and operating costs significantly increased to $545,794 in Q1 2026 from $40,423 in Q1 2025.
  • Interest earned on marketable securities in the trust account rose to $785,555 in Q1 2026 from $417,209 in Q1 2025.
  • Total assets as of March 31, 2026, were $90,313,170, up from $89,528,052 at December 31, 2025.
  • Shareholders' deficit increased to $(6,574,807) as of March 31, 2026, from $(6,029,708) at December 31, 2025.
  • The company reported a working capital deficit of $2,424,808 as of March 31, 2026.
  • Management identified substantial doubt about the company's ability to continue as a going concern.
  • The company is pursuing a business combination with GOWell Technology Limited, with a completion window until August 14, 2026.